Yerry Rodriguez

The Rangers announced that right-hander Jacob deGrom has been placed on the 15-day injured list due to inflammation in his throwing elbow.  The move comes a day after deGrom was removed early from his start against the Yankees due to what was initially termed as forearm tightness.  In the corresponding move, Texas called up right-hander Yerry Rodriguez from Triple-A to take deGrom’s spot on the active roster.

Manager Bruce Bochy told reporters yesterday that removing deGrom was “just a precaution,” and GM Chris Young told reporters (including Shawn McFarland of the Dallas Morning News) that an MRI revealed the inflammation.  “Given how important he is to us and our season, we’re going to play this very cautiously and see how he responds over the next several days of treatment, and then 7-10 days we’ll have a pretty good idea of what the next steps are,” Young said.

DeGrom also made an early exit from a start two weeks ago due to wrist soreness, this IL visit might be something more of an overall maintenance pause to let deGrom entirely heal up.  That said, it certainly isn’t good to see deGrom back on the IL, particularly with any sort of elbow/forearm issue.  The right-hander underwent Tommy John surgery over a decade ago, and he missed the second half of the 2021 season recovering from forearm tightness.  Between that abbreviated 2021 season and then a stress reaction in his shoulder blade prior to the start of the 2022 season, deGrom missed almost exactly a full year of action bridged over the 2021-22 campaigns.

Sandwiched around that long injury absence, deGrom still posted a 1.90 ERA over 156 1/3 innings in 2021-22, continuing to show that he is one of baseball’s very best pitchers when healthy.  Even with health concerns clouding his last two seasons, deGrom still opted out of the $30.5MM remaining on his contract with the Mets in order to chase a larger free agent deal this past winter.  The bet paid off handsomely for the 34-year-old, who landed a five-year, $185MM contract from the Rangers.

That deal contains a conditional option for the 2028 season that is relevant given the nature of deGrom’s current IL stint.  The option becomes a club option if deGrom undergoes a TJ surgery or is on the IL for any elbow or shoulder-related injury for either 130 consecutive days in a given season, or for 186 consecutive days bridging multiple season.  (The price of that club option ranges from $20MM to as much as $37MM if deGrom hits certain innings thresholds and finishes in Cy Young Award voting over the life of the contract.)  If deGrom avoids these injury benchmarks, passes a physical after the 2027 season, tossed at least 160 innings that season, and has a top-five finish in Cy Young voting in 2027, the option becomes a $37MM player option.

As noted, there isn’t yet any indication that deGrom’s injury is serious, or anything that might even sideline him beyond the 15-day minimum.  Still, it is a little ominous that an elbow problem that sent deGrom to the IL within his first month in a Rangers uniform, and the club can only hope that this injury is just a bump in the road.

Over his first six games with Texas, deGrom has continued to perform like an ace, posting a 2.67 ERA over 30 1/3 innings with elite Statcast metrics almost across the board.  The Rangers are a perfect 6-0 in deGrom’s starts, which is a big reason why Texas is sitting in first place in the AL West after a 15-11 start.

Texas has off-days on both Monday and Thursday, giving the team some flexibility in how it will reset the rotation with deGrom out.  Young indicated that Dane Dunning is the likeliest candidate to step into the starting five, and Rodriguez’s promotion is perhaps a hint that the Rangers will indeed move Dunning back into the rotation.  Dunning was a regular starter for the Rangers in 2021-22 before the team’s offseason pitching acquisitions pushed him into a relief role.  Despite a very low 13.9% strikeout rate, Dunning has fared well in the bullpen, posting a 1.77 ERA and 50.8% grounder rate over 20 1/3 relief innings.